Literature DB >> 25959679

High Emergency Lung Transplantation: dramatic decrease of waiting list death rate without relevant higher post-transplant mortality.

Antoine Roux1,2, Laurence Beaumont-Azuar1, Abdul Monem Hamid1, Sandra De Miranda1, Dominique Grenet1, Guillaume Briend1,3, Pierre Bonnette4, Philippe Puyo4, François Parquin5, Jerome Devaquet6, Gregoire Trebbia6, Elise Cuquemelle5, Benoit Douvry1, Clément Picard1, Morgan Le Guen7, Alain Chapelier4, Marc Stern1, Edouard Sage4.   

Abstract

Many candidates for lung transplantation (LT) die on the waiting list, raising the question of graft availability and strategy for organ allocation. We report the experience of the new organ allocation program, "High Emergency Lung Transplantation" (HELT), since its implementation in our center in 2007. Retrospective analysis of 201 lung transplant patients, of whom 37 received HELT from 1st July 2007 to 31th May 2012. HELT candidates had a higher impairment grade on respiratory status and higher Lung Allocation Score (LAS). HELT patients had increased incidence of perioperative complications (e.g., perioperative bleeding) and extracorporeal circulatory assistance (75% vs. 36.6%, P = 0.0005). No significant difference was observed between HELT and non-HELT patients in mechanical ventilation duration (15.5 days vs. 11 days, P = 0.27), intensive care unit length of stay (15 days vs. 10 days, P = 0.22) or survival rate at 12 (81% vs. 80%), and 24 months post-LT (72.9% vs. 75.0%). Lastly, mortality on the waiting list was spectacularly reduced from 19% to 2% when compared to the non-HELT 2004-2007 group. Despite a more severe clinical status of patients on the waiting list, HELT provided similar results to conventional LT. These results were associated with a dramatic reduction in the mortality rate of patients on the waiting list.
© 2015 Steunstichting ESOT.

Entities:  

Keywords:  graft allocation; lung transplantation; mortality on waiting list

Mesh:

Year:  2015        PMID: 25959679     DOI: 10.1111/tri.12604

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  4 in total

Review 1.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

2.  Outcomes and risk factors identification in urgent lung transplantation: a multicentric study.

Authors:  Marco Schiavon; Giulio Faggi; Lorenzo Rosso; Luca Luzzi; Giovanni Maria Comacchio; Dario Gregori; Mario Nosotti; Francesco Damarco; Andrea Dell'Amore; David Bennet; Antonella Fossi; Piero Paladini; Luigi Santambrogio; Federico Rea
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

3.  Commentary: "To list, or not to list? That is the question".

Authors:  Jing Yu Chen; Michael K Y Hsin
Journal:  J Thorac Cardiovasc Surg       Date:  2020-03-20       Impact factor: 5.209

4.  Extracorporeal membrane oxygenation as a bridge to lung transplantation in a Turkish lung transplantation program: our initial experience.

Authors:  Mustafa Vayvada; Yesim Uygun; Sevinc Cıtak; Ertan Sarıbas; Atakan Erkılıc; Erdal Tasci
Journal:  J Artif Organs       Date:  2020-08-27       Impact factor: 1.731

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.